I mean the answer is still clearly “yes”. The FDA revoked the EUA after it requested its voluntary withdrawal after all does expired last month. Nothing new here- we’ve talked about ViTTP for a long time as being a rare complication of the J&J vaccine. Although rare, it did result in the recommendation for the mRNA vaccines for most people, as it didn’t have that rare association. But its safety profile was still obviously way better than the “safety profile” of a primary Covid infection in an immune naive individual during the pandemic phase.